StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2022 - 06 - 13
6
2022 - 06 - 07
6
2022 - 05 - 24
6
2022 - 05 - 23
8
2022 - 04 - 06
6
2022 - 03 - 26
6
2022 - 03 - 07
7
2022 - 01 - 05
6
2022 - 01 - 04
8
2021 - 12 - 14
9
2021 - 12 - 13
6
2021 - 12 - 09
6
2021 - 12 - 06
10
2021 - 11 - 15
8
2021 - 10 - 25
7
2021 - 10 - 18
6
2021 - 09 - 29
8
2021 - 09 - 27
6
2021 - 09 - 16
6
2021 - 09 - 15
9
2021 - 08 - 31
6
2021 - 08 - 16
10
2021 - 08 - 05
6
2021 - 07 - 06
6
2021 - 06 - 28
9
2021 - 06 - 23
6
2021 - 06 - 17
6
2021 - 06 - 16
8
2021 - 06 - 11
9
2021 - 06 - 10
6
2021 - 06 - 08
8
2021 - 06 - 07
8
2021 - 06 - 04
8
2021 - 06 - 03
6
2021 - 06 - 01
7
2021 - 05 - 25
6
2021 - 05 - 19
8
2021 - 05 - 03
11
2021 - 04 - 23
7
2021 - 04 - 13
7
2021 - 04 - 12
9
2021 - 04 - 08
5
2021 - 03 - 23
6
2021 - 03 - 17
5
2021 - 03 - 16
9
2021 - 03 - 15
8
2021 - 03 - 10
6
2021 - 03 - 02
5
2021 - 02 - 25
7
2021 - 02 - 22
5
2021 - 02 - 12
5
2021 - 01 - 25
5
2021 - 01 - 19
5
2020 - 12 - 21
9
2020 - 12 - 17
7
2020 - 12 - 15
5
2020 - 12 - 10
9
2020 - 12 - 09
8
2020 - 12 - 07
10
2020 - 12 - 03
5
Sector
Health technology
5
Tags
5g
2
Acquisition
9
Acquisition corp
4
Alliances
2
Anavex
2
Antibody
2
Application
2
Approval
2
Awards
5
Biomidwest
2
Bioscience
3
Biotech
2
Biotech-beach
2
Cancer
3
Ceo
3
Clinical-trials-phase-ii
2
Clinical-trials-phase-iii
2
Commercialization
3
Conference
17
Contract
4
Covid
8
Covid-19
3
Disease
8
Distribution
4
Energy
10
Events
5
Fda
6
Financial results
30
Genetown
3
Growth
4
Health
9
Leo
3
License
3
Life science
3
Media
5
Mobile
3
N/a
263
Offering
11
People
3
Pharma
3
Phase 2
4
Phase 3
5
Positive
3
Presentation
9
Product-news
6
Program
4
Publication
4
Rare
3
Redemptions
3
Research
3
Results
55
Solar
3
Spac
3
Svb leerink global
6
System
5
Test
5
Therapeutics
7
Treatment
4
Trial
4
Vaccine
7
Entities
Abbvie inc.
1
Cassava sciences, inc.
1
Morphic holding, inc.
1
Novavax, inc.
1
Otonomy, inc.
1
Symbols
ABBV
1
MORF
1
NVAX
1
OTIC
1
SAVA
1
Exchanges
Nasdaq
4
Nyse
1
Crawled Date
2021 - 02 - 22
5
Crawled Time
12:03
2
14:00
1
14:01
1
15:00
1
Source
www.biospace.com
2
www.globenewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 02 - 22
tags :
Phase 3
save search
Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ™) Improved Clinical, Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients
Published:
2021-02-22
(Crawled : 15:00)
- biospace.com/
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
57.28%
|
O:
-0.33%
H:
2.89%
C:
2.29%
phase 3
ulcerative colitis
Cassava Sciences Announces Positive End-of-Phase 2 Meeting with FDA and Outlines Pivotal Phase 3 Program for Simufilam in Alzheimer’s Disease
Published:
2021-02-22
(Crawled : 14:01)
- globenewswire.com
SAVA
|
$21.18
-0.42%
-0.42%
970K
|
Health Technology
|
-61.85%
|
O:
17.89%
H:
0.0%
C:
-19.34%
disease
alzheimer
fda
phase 2
positive
phase 3
alzheimer’s
alzheimer's disease
alzheimer's
Morphic Therapeutic to Host Analyst and Investor Call on March 1, 2021Call to discuss financial and operational results for fiscal year 2020 and MORF-057 interim data from SAD portion of ongoing MORF-057 Phase 1 clinical trial
Published:
2021-02-22
(Crawled : 14:00)
- biospace.com/
MORF
|
$27.5
-1.33%
-1.35%
370K
|
Health Technology
|
-23.35%
|
O:
-1.73%
H:
0.78%
C:
-3.64%
phase 1
results
trial
phase 3
phase 2
ongoing
Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico
Published:
2021-02-22
(Crawled : 12:03)
- globenewswire.com
NVAX
|
$3.9
0.26%
0.26%
2.8M
|
Health Technology
|
-98.6%
|
O:
-3.56%
H:
3.41%
C:
-8.55%
covid
vaccine
phase 3
trial
enroll
Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease
Published:
2021-02-22
(Crawled : 12:03)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-98.56%
|
O:
-49.54%
H:
23.53%
C:
10.29%
disease
results
phase 3
trial
topline
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.